This study compares Durva Ghrita and Shatavari Ghrita for Pittaj Yonivypad (vulvovaginitis) using a randomized trial to assess their effectiveness through oral intake (Pan) and local application (Pichu).

Randomized controlled clinical trial to evaluate efficacy of durva ghrita pan and pichu with shatavari ghrita pan and pichu in the management of pittaja yonivyapad with special reference to vulvovaginitis. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/083625

Enrollment

Registered

2025-03-28

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N77- Vulvovaginal ulceration and inflammation in diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: - Diagnosed cases of pittaj yonivyapad having signs and symptoms of pittaj yonivyapad like yonidaha, yonipaka, neela peeta asita yonigat strav. - Married females - Irrespectives of caste, religion,social economical status

Exclusion criteria

Exclusion criteria: 1) Pregnant females 2) During Menses 3) H/O Diabetes mellitus 4) Patients with vulvovaginitis when seen associated with prolapsed uterus 5) HIV,HBsAg,VDRL positive 6) Patients with benign and malignant tumours of uterus. 7) Patients who requires surgical intervention in cases like pelvic abcess, tuboovarian mass patients associted with genital tubercular infections 8) Patients with sexually transmitted diseases

Design outcomes

Primary

Measure	Time frame
The primary outcome focuses on the clinical efficacy of Durva Ghrita (pan and pichu) vs. Shatavari Ghrita (pan and pichu) in managing Pittaja Yonivyapad (Vulvovaginitis). It will be assessed based on symptomatic relief (Yoni Daha, Yoni Pak, Mutradaha, Artavagandha, Stravpraman, Strav character) and objective parameters (Aartavpraman). Assessments will occur at baseline, during treatment, post-treatment, and follow-ups.Timepoint: 1 week	—

Measure

Time frame

The primary outcome focuses on the clinical efficacy of Durva Ghrita (pan and pichu) vs. Shatavari Ghrita (pan and pichu) in managing Pittaja Yonivyapad (Vulvovaginitis). It will be assessed based on symptomatic relief (Yoni Daha, Yoni Pak, Mutradaha, Artavagandha, Stravpraman, Strav character) and objective parameters (Aartavpraman). Assessments will occur at baseline, during treatment, post-treatment, and follow-ups.Timepoint: 1 week

—

Secondary

Measure	Time frame
Study aims to compare the effects of Durva Ghrita & Shatavari Ghrita in managing Pittaja Yonivyapad, focusing on both their internal (pan) & local (pichu) applications. 1. Detailed analysis of the guna & karma of Durva Ghrita & Shatavari Ghrita. 2. A comprehensive review of Pittaja Yonivyapad based on Ayurvedic Samhitas. 3. A detailed study of vulvovaginitis from a modern medical perspective. 4. A comparative assessment of the efficacy of both Ghritas in managing symptomsTimepoint: 1 week	—

Measure

Time frame

Study aims to compare the effects of Durva Ghrita & Shatavari Ghrita in managing Pittaja Yonivyapad, focusing on both their internal (pan) & local (pichu) applications. 1. Detailed analysis of the guna & karma of Durva Ghrita & Shatavari Ghrita. 2. A comprehensive review of Pittaja Yonivyapad based on Ayurvedic Samhitas. 3. A detailed study of vulvovaginitis from a modern medical perspective. 4. A comparative assessment of the efficacy of both Ghritas in managing symptomsTimepoint: 1 week

—

Countries

India

Contacts

Public ContactDr Tulsi Das

L.K.R.Ayurvedic Mahavidyalay PG Training and Research Center , Gadhinglaj

saritakamate9@gmail.com9881988389

Outcome results